CEP97 抗体 (AA 568-617)
Quick Overview for CEP97 抗体 (AA 568-617) (ABIN2894796)
抗原
See all CEP97 抗体适用
宿主
克隆类型
标记
应用范围
- 
    - 
                                            抗原表位
- AA 568-617
- 
                                            特异性
- CEP97 antibody detects endogenous levels of CEP97.
- 
                                            纯化方法
- Immunoaffinity purified
- 
                                            免疫原
- 
                        Synthetic peptide derived from human CEP97 (aa568-617).
 Type of Immunogen: Synthetic peptide
- 
                                            亚型
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            应用备注
- Approved: Peptide-ELISA (1:10000), WB (1:500 - 1:1000)
- 
                                            说明
- 
                        Target Species of Antibody: Human 
- 
                                            限制
- 仅限研究用
 
- 
                                            
- 
    - 
                                            状态
- Liquid
- 
                                            浓度
- Lot specific
- 
                                            缓冲液
- PBS, pH 7.4, 150 mM sodium chloride, 0.02 % sodium azide, 50 % glycerol.
- 
                                            储存液
- Sodium azide
- 
                                            注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 
                                            储存条件
- -20 °C
- 
                                            储存方法
- Store at -20°C.
 
- 
                                            
- 
    - CEP97 (Centrosomal Protein 97kDa (CEP97))
- 
                                            别名
- CEP97
- 
                                            背景
- 
                        Name/Gene ID: CEP97
 Synonyms: CEP97, Centrosomal protein of 97 kDa, Centrosomal protein 97 kDa, LRRIQ2
- 
                                            基因ID
- 79598
 抗原
- 
                    
 
                                     
                                     
                                    